Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Globe Newswire•24/08/2026•09:25 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.